Sam Bankman-Fried isn't going down without a fight. The disgraced FTX founder on Tuesday pleaded not guilty on all counts, including multiple charges of fraud and conspiracy.
Bankman-Fried, 30, is going a different route than his co-executives at FTX: Gary Wang, co-founder of FTX, and Caroline Ellison, CEO of Alameda Research, have both pleaded guilty.
Indeed, there is widespread consensus that FTX's leadership engaged in criminal activity. Even current CEO John J. Ray III has described the situation as "old-fashioned embezzlement."
The U.S. attorney of the Southern District of New York filed the charges in December, along with parallel actions from the Securities and Exchange Commission (SEC) and the Commodity Futures Trading Commission (CFTC).
Senior Economist at Morning Consult Kayla Bruun shares thoughts on what to expect from the Fed's January meeting and where monetary policy is headed, as well as how consumers are faring.
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
